Diagnosed with Mesothelioma? Call 877-MESOTHELIOMA or Live Chat now for a Free Legal Compensation Consultation

New Drugs Rally Immune System to Fight Cancer

For many years, cancer researchers have questioned why the immune system doesn’t react to cancer cells as invaders and attack them. A deepening understanding of genetic drivers of disease reveals that the cancerous tumors take over the brake control on the immune system.

A recent article in The Wall Street Journal underscores the advances being made in new drugs that release the brake and allow the immune system to fight various forms of cancer, including cancers associated with asbestos exposure.

For Tom Stutz, a 72-year-old retired lawyer in California, taking each breath was a struggle and even doing simple tasks such as eating a meal required help as cancer advanced in his lungs and liver.  In April, Stutz, who was confined to a wheelchair, began taking an experimental drug known as MK-3475 that reactivated his immune system to fight cancer. Today, Mr. Stutz is walking 3.5 miles a day, has parked his wheelchair, and reports feeling terrific, according to The Wall Street Journal article about innovative medical treatments. Doctors informed Mr. Stutz in the fall that his tumors had shrunk by 65 percent.

MK-3475, which has not yet been approved by the U.S. Food and Drug Administration, is under development by Merck & Co. It is among a class of drugs known as PD-1 inhibitors. The drugs disrupt the ability of cancer to hijack the immune system and boosts the immune response to certain cancers. In testing the drug on patients with metastatic melanoma, researchers reported in November that about 9 percent of patients who took the drug has no observable cancer after 12 weeks while half of the study participants had tumor shrinkage.

Merck is currently recruiting cancer patients to participate in clinical trials to study the safety and tolerability of the drug to treat several forms of cancer including non-small cell lung cancer, one of the cancers associated with asbestos exposure. You can find contact information about the clinical trial here.

Download Your Free Mesothelioma Handbook & Treatment Guide

Free Mesothelioma Patient

& Treatment Guide

We’d like to offer you our in-depth guide, “A Patient’s Guide to Mesothelioma,” absolutely free of charge.

It contains a wealth of information and resources to help you better understand the condition, choose (and afford) appropriate treatment, and exercise your legal right to compensation.

HONcode Certified

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Office Location

Last Modified: November 21, 2018

Copyright 2019 MesotheliomaHelp.org
The information provided by Mesothelioma Help is not a substitute for professional medical advice, diagnosis or treatment.
Our website does not host any form of advertisement.

Mesothelioma Help Cancer Organization is sponsored by Belluck & Fox, LLP
Site by Consultwebs